Kyverna Therapeutics

CAR T-cell therapy drives severe arthritis into remission in first trial

Researchers at Charité—Universitätsmedizin Berlin have demonstrated for the first time that CAR T-cell therapy can drive severe rheumatoid arthritis into sustained remission, according to results from the COMPARE trial published in Nature Medicine on August 27, 2026. Disease activity decreased…